Arvanitakis Marianna, Van Laethem Jean-Luc, Pouzere Sylvain, Le Moine Olivier, Deviere Jacques
Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium.
Hepatogastroenterology. 2006 Jan-Feb;53(67):21-7.
BACKGROUND/AIMS: Biliary stenting is the treatment of choice for inoperable cholangiocarcinomas of the hilum (Klatskin tumors). The aim of this study was to define factors predicting 1) successful biliary drainage and 2) survival.
This is a retrospective study of 48 patients with Bismuth's type I-II (n=15) and III-IV (n=33) strictures who were treated endoscopically (combined with percutaneous techniques if required), aiming to obtain complete resolution of jaundice. Prognostic variables for 1) successful drainage at 30 days and 2) survival at 12 months were analyzed.
Drainage resulting in complete resolution of jaundice was obtained in 31/48 patients (65%). Baseline bilirubinemia was the only predicting factor of a successful drainage. Median survival was 202 days. The absence of a mass-type tumor or liver metastases, the absence of complications and successful drainage were identified as independent factors predicting survival at 12 months. Bilateral drainage with more than two stents was associated with a longer survival rate in patients with Bismuth III-IV tumors (271 versus 90 days) (p<0.050).
In Klatskin tumors, resolution of jaundice through an optimal stenting results in a better survival rate. Additional independent predictive factors are the absence of a mass-type tumor, liver metastases and post-drainage complications.
背景/目的:胆管支架置入术是肝门部无法切除的胆管癌(克氏壶腹肿瘤)的首选治疗方法。本研究的目的是确定预测以下两点的因素:1)胆管引流成功;2)生存率。
这是一项对48例患有毕氏I-II型(n = 15)和III-IV型(n = 33)狭窄的患者进行的回顾性研究,这些患者接受了内镜治疗(必要时联合经皮技术),旨在完全消除黄疸。分析了以下两点的预后变量:1)30天时引流成功;2)12个月时的生存率。
48例患者中有31例(65%)的引流使黄疸完全消退。基线胆红素血症是引流成功的唯一预测因素。中位生存期为202天。无肿块型肿瘤或肝转移、无并发症以及引流成功被确定为预测12个月生存率的独立因素。对于毕氏III-IV型肿瘤患者,使用两个以上支架进行双侧引流与更长的生存率相关(271天对90天)(p < 0.050)。
在克氏壶腹肿瘤中,通过最佳支架置入术消除黄疸可提高生存率。其他独立的预测因素包括无肿块型肿瘤、肝转移和引流后并发症。